⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Zurich Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Zurich Pharma
↗Mexico City, Mexico
Zurich Pharma is a privately held Mexican pharmaceutical company established in 2004 and focused on manufacturing high-specialty and oncology medicines for public- and private-sector healthcare markets. Its portfolio includes oncology products and medicines used in transplantation, autoimmune disease, multiple sclerosis, critical care, and related specialty-care settings. The company reports 51 active ingredients, 69 presentations, more than 45 registrations in Latin America, and a technology platform for liposomal and microparticle drug-delivery products. ([zurichpharma.com.mx](https://www.zurichpharma.com.mx/?utm_source=openai))
The company operates corporate offices in Miguel Hidalgo, Mexico City, and a manufacturing plant in Noxtongo, Tepeji del Río, Hidalgo. Public materials describe capabilities spanning solids, injectables, lyophilized products, soft-gelatin capsules, prefilled syringes, liposomes, and microparticles. The company remains operationally active based on current product listings, 2025 public-sector contracting records, and 2026 recruiting activity for plant, validation, metrology, documentation, production, and IT roles. ([zurichpharma.com.mx](https://www.zurichpharma.com.mx/?utm_source=openai))
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty and oncology pharmaceuticals; high-specialty generic drug manufacturing
SIZE & FINANCIALS
Employees:51-200
Founded:2004
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecules, Generic injectables, Oral solid dosage forms, Liposomes, Microparticles, Lyophilized products, Soft-gelatin capsules, Prefilled syringes
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Corden Pharma — Zurich Pharma states that it represents the product Neleprit (propofol), associated with Corden Pharma; commercial terms and agreement date were not disclosed. ([zurichpharma.com.mx](https://www.zurichpharma.com.mx/?utm_source=openai)), Reus Pharma — a public testimonial from Zurich Pharma General Director Mayelin Silva Fernández describes collaboration with Reus on pharmaceutical commercialization and strategic partners; formal deal terms were not disclosed. ([reuspharma.com](https://reuspharma.com/services?utm_source=openai)), AMELAF — Zurich Pharma is listed as a member of the Asociación Mexicana de Laboratorios Farmacéuticos. ([amelaf.org.mx](https://amelaf.org.mx/en/socios/?utm_source=openai))
COMPETITION
Position:Niche Player
Competitors:Laboratorios PiSA, Neolpharma, Fresenius Kabi México, Teva Pharma México, Sun Pharma de México, Accord Farma, Tecnofarma, Laboratorios Aspen
LEADERSHIP
Key Executives:
Mayelin Silva Fernández - Directora General
Orlando Silva Fernández - Founder and historic General Manager
Omar Álvarez Moscoso - Publicly identified legal representative / privacy contact
LINKS
Website:zurichpharma.com.mx
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Zurich Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.